Menu Close

Published studies

  • Impact on follow-up strategies in patients with primary sclerosing cholangitis. Bergquist A, Weismüller TJ, Levy C, Rupp C, Joshi D, Nayagam JS et al. Liver International 2022.
  • Defining Primary Sclerosing Cholangitis: Results From an International Primary Sclerosing Cholangitis Study Group Consensus Process. Ponsioen, C. Y., Assis, D. N., Boberg, K. M., Bowlus, C. L., Deneau, M., Thorburn, D., et al. Gastroenterology 2021 
  • Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group. Venkatesh, S. K., Welle, C. L., Miller, F. H., Jhaveri, K., Ringe, K. I., Eaton, J. E., et al. Springer Nature 2021
  • Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis.  Hedin, et al. CGH2020
  • Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases. Kate D. Lynch, Roger W. Chapman, Satish Keshav, et al. CGH 2020.
  • Recommendations on the Use of Magnetic Resonance Imaging for Collaborative Multicenter Studies in Primary Sclerosing Cholangitis. Hepatology 2018.
  • No superiority of stents vs balloon dilatation for dominant strictures in patients with primary sclerosing cholangitis.  Gastroenterology 2018
  • Design and endpoints for clinical trials in primary sclerosing cholangitis. Hepatology 2018
  • Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease. Nature Genetics 2017    The summary statistics are available here
  • Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis. GUT 2017
  • Recommendations on the use of magnetic resonance imaging in PSC-A position statement from the International PSC Study Group. Hepatology 2017
  • Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis. Gastroenterology 2017
  • Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease. Nat Genetic 2017
  • HLA haplotypes in primary sclerosing cholangitis patients of admixed and non-European ancestry. HLA2017
  • Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre study. Liver Int 2017
  • Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: An international cohort study. Hepatology 2017
  • Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci. Nat Genetic 2016
  • Surrogate endpoints for clinical trials in primary sclerosing cholangitis: Review and results from an International PSC Study Group consensus process. Hepatology 2015
  • Enhanced liver fibrosis score predicts transplant-free survival in primary sclerosing cholangitis Hepatology 2015
  • Characterization of animal models for primary sclerosing cholangitis J Hepatol 2014
  • Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis Nat Genetics 2013